封面
市场调查报告书
商品编码
1701761

单细胞分析市场规模、份额、成长分析(按产品、细胞类型、技术、应用、最终用户、地区)- 产业预测 2025-2032

Single Cell Analysis Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Technique, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球单细胞分析市场规模为 43.4 亿美元,预计将从 2024 年的 51.5 亿美元成长到 2032 年的 203 亿美元,预测期内(2025-2032 年)的复合年增长率为 18.7%。

由于药物发现、疾病筛检和癌症发生率不断上升等多种应用,单细胞分析市场正在经历显着增长。定序技术的进步增强了分析和分离单一细胞的能力,从而可以精确检查单一细胞的转录组和基因组。这种详细的分析揭示了细胞对生理变化的独特反应,揭示了不同的谱系和功能。根据 Clinicaltrials.gov 报导,该技术在 22 项 II 期临床研究中的应用证明了其快速发展。单细胞分析对于理解生物复杂性至关重要,并且正在扩展到免疫学和其他领域。现代定序可以在一次实验中分析数千到数百万个细胞,为诊断和研究创造了充足的机会,推动了市场成长。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管格局
  • 贸易分析

单细胞分析市场规模(按产品和复合年增长率) (2025-2032)

  • 市场概览
  • 耗材
    • 试剂和套件
    • 微孔盘
    • 滑动
    • 其他耗材
  • 装置
    • 流式细胞仪
    • 次世代定序(NGS)平台
    • 聚合酵素链锁反应(PCR)设备
    • 显微镜
    • 质谱流式细胞仪
    • 其他的
  • 软体和服务
    • 数据分析软体
    • 影像软体
    • 定序资料解释工具
    • 客自订服务

单细胞分析市场规模(依细胞类型及复合年增长率)(2025-2032)

  • 市场概览
  • 人类细胞
  • 动物细胞
  • 微生物细胞
  • 植物细胞

单细胞分析市场规模(依技术及复合年增长率)(2025-2032)

  • 市场概览
  • 流式细胞技术
  • 次世代定序
  • 定量PCR
  • 基于显微镜的技术
  • 其他的

单细胞分析市场规模(依应用)及复合年增长率(2025-2032)

  • 市场概览
  • 调查应用
    • 基因组学
    • 转录组学
    • 蛋白质体学
    • 表观基因
    • 代谢体学
  • 临床应用
    • 癌症
    • 免疫学
    • 神经病学
    • 感染疾病
    • 产前检查
    • 罕见疾病检测
  • 干细胞研究
  • 药物研发
  • 其他的

单细胞分析市场规模(依最终用户和复合年增长率)(2025-2032)

  • 市场概览
  • 学术研究所
  • 製药和生物技术公司
  • 医院和诊断实验室
  • 合约研究组织(CRO)
  • 政府和监管机构

单细胞分析市场规模(按地区)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Danaher Corporation-USA
  • Thermo Fisher Scientific Inc.-USA
  • Merck KGaA-Germany
  • 10x Genomics-USA
  • BD(Becton, Dickinson and Company)-USA
  • QIAGEN-Netherlands
  • CYTENA GmbH-Germany
  • Sartorius AG-Germany
  • Tecan Trading AG-Switzerland
  • Takara Bio Inc.-Japan
  • BIOMERIEUX-France
  • Agilent Technologies, Inc.-USA
  • Standard BioTools-USA
  • Bio-Rad Laboratories, Inc.-USA
  • Illumina, Inc.-USA
  • RareCyte, Inc.-USA
  • On-chip Biotechnologies Co., Ltd-Japan
  • Oxford Nanopore Technologies plc-UK
  • BGI-China
  • Novogene Co., Ltd-China

结论和建议

简介目录
Product Code: SQMIG35G2160

Global Single Cell Analysis Market size was valued at USD 4.34 billion in 2023 and is poised to grow from USD 5.15 billion in 2024 to USD 20.3 billion by 2032, growing at a CAGR of 18.7% during the forecast period (2025-2032).

The Single Cell Analysis Market is experiencing significant growth driven by its diverse applications in drug discovery, disease screening, and the increasing prevalence of cancer. Advances in sequencing technology have enhanced single-cell analysis and isolation capabilities, enabling precise examination of individual cell transcriptomes and genomes. This detailed analysis uncovers unique cellular responses to physiological changes, revealing various lineages and functions. The technology's rapid evolution is evident, with its application in 22 phase-II clinical studies, as reported on Clinicaltrials.gov. Single-cell analysis is now crucial for understanding biological complexity, expanding into immunology and other fields. Modern sequencing allows for the analysis of thousands to millions of cells in one experiment, creating ample opportunities for diagnostics and research, thereby propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Cell Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Cell Analysis Market Segments Analysis

Global Single Cell Analysis Market is segmented by Product, Cell Type, Technique, Application, By End User and region. Based on Product, the market is segmented into Consumables, Instruments and Software & Services. Based on Cell Type, the market is segmented into Human Cells, Animal Cells, Microbial Cells and Plant Cells. Based on Technique, the market is segmented into Flow Cytometry, Next-Generation Sequencing, Quantitative PCR, Microscopy-based Techniques and Others. Based on Application, the market is segmented into Research Applications, Clinical Applications, Stem Cell Research, Drug Discovery & Development and Others. Based on By End User, the market is segmented into Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations (CROs) and Government & Regulatory Bodies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Cell Analysis Market

Recent advancements in mass cytometry and next-generation sequencing (NGS) have significantly improved the precision and detail of single-cell analysis techniques. These innovations allow researchers to gather comprehensive data on individual cells, paving the way for enhanced studies in immunology and cancer research. As a result, there has been a remarkable surge in demand for single-cell analytic technologies, driving the rapid growth of the Single Cell Analysis Market and attracting increased funding for research and development. This momentum highlights the crucial role of cutting-edge tools in advancing our understanding of complex biological systems and disease mechanisms.

Restraints in the Global Single Cell Analysis Market

One of the primary challenges facing the global single-cell analysis market is the substantial cost associated with advanced technologies and machinery. High-throughput sequencing systems and various single-cell analysis tools necessitate significant initial investments, which can be prohibitively expensive for many smaller laboratories and research institutions. This financial barrier can hinder their ability to acquire cutting-edge single-cell analysis equipment, ultimately limiting their capacity to engage in innovative research. As a result, the high costs associated with these technologies pose a significant constraint on the growth and expansion of the overall single-cell analysis market, making accessibility more difficult.

Market Trends of the Global Single Cell Analysis Market

The Global Single Cell Analysis market is witnessing a transformative trend with the integration of artificial intelligence (AI) and machine learning. These advanced technologies are revolutionizing the processing of complex data sets generated from single-cell experiments, enhancing data interpretation and enabling researchers to uncover significant biological insights with greater efficiency. By automating data pattern recognition, AI expedites the discovery process for scientists, illuminating cellular activities and disease mechanisms in unprecedented ways. As a result, the market is set to expand rapidly, driven by increased demand for innovative solutions that combine cutting-edge analytics with single-cell technologies, ultimately fostering advancements in personalized medicine and genomics.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Trade Analysis

Global Single Cell Analysis Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Consumables
    • Reagents & Kits
    • Microplates
    • Beads
    • Slides
    • Other Consumables
  • Instruments
    • Flow Cytometers
    • Next-Generation Sequencing (NGS) Platforms
    • Polymerase Chain Reaction (PCR) Instruments
    • Microscopes
    • Mass Cytometers
    • Others
  • Software & Services
    • Data Analysis Software
    • Imaging Software
    • Sequencing Data Interpretation Tools
    • Custom Services

Global Single Cell Analysis Market Size by Cell Type & CAGR (2025-2032)

  • Market Overview
  • Human Cells
  • Animal Cells
  • Microbial Cells
  • Plant Cells

Global Single Cell Analysis Market Size by Technique & CAGR (2025-2032)

  • Market Overview
  • Flow Cytometry
  • Next-Generation Sequencing
  • Quantitative PCR
  • Microscopy-based Techniques
  • Others

Global Single Cell Analysis Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Research Applications
    • Genomics
    • Transcriptomics
    • Proteomics
    • Epigenomics
    • Metabolomics
  • Clinical Applications
    • Cancer
    • Immunology
    • Neurology
    • Infectious Diseases
    • Prenatal Diagnosis
    • Rare Disease Detection
  • Stem Cell Research
  • Drug Discovery & Development
  • Others

Global Single Cell Analysis Market Size by By End User & CAGR (2025-2032)

  • Market Overview
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Government & Regulatory Bodies

Global Single Cell Analysis Market Size & CAGR (2025-2032)

  • North America (Product, Cell Type, Technique, Application, By End User)
    • US
    • Canada
  • Europe (Product, Cell Type, Technique, Application, By End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Cell Type, Technique, Application, By End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Cell Type, Technique, Application, By End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Cell Type, Technique, Application, By End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Danaher Corporation - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company) - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN - Netherlands
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CYTENA GmbH - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG - Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tecan Trading AG - Switzerland
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. - Japan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOMERIEUX - France
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Standard BioTools - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RareCyte, Inc. - USA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • On-chip Biotechnologies Co., Ltd - Japan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc - UK
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI - China
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd - China
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations